# AEON Biopharma, Inc.: Form SCHEDULE 13D, filed Jan 29, 2026

- Company: [AEON Biopharma, Inc.](/companies/aeon.md) (CIK 1837607)
- Form: SCHEDULE 13D
- Filed: 2026-01-29
- Accepted by EDGAR: Jan 29, 2026, 21:24 ET
- Period: not reported
- Accession: 0001213900-26-009802
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1837607/000121390026009802/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1837607/000121390026009802/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1837607/000121390026009802/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-009802. Last ingested by Listed: Nov 3, 2026, 09:04 ET. No prices; not investment advice.